Zobrazeno 1 - 10
of 2 909
pro vyhledávání: '"Schottelius, M"'
Autor:
Enke JS; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Ritzel K; Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany., Asbach E; Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany., Reitsam NG; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Märkl B; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Knösel T; Institute of Pathology, Ludwig Maximilians University Hospital Munich, Munich, Germany., Brüdgam D; Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany., Kircher M; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Pfob CH; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Bundschuh RA; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Rinscheid A; Medical Physics and Radiation Protection, University Hospital Augsburg, Augsburg, Germany., Nittbaur B; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Wienand G; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Schottelius M; Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, Switzerland; and.; SCCL Swiss Cancer Center Leman, Lausanne, Switzerland., Reincke M; Department of Medicine IV, Ludwig Maximilians University Hospital Munich, Munich, Germany., Lapa C; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany; constantin.lapa@uk.augsburg.de., Dierks A; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1640-1644. Date of Electronic Publication: 2024 Oct 01.
Autor:
Petruzzella A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland., Bruand M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland., Santamaria-Martínez A; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland., Katanayeva N; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland., Reymond L; Institute of Chemical Sciences and Engineering (ISIC), Institute of Bioengineering, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland., Wehrle S; Laboratory of Protein Design and Immunoengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland., Georgeon S; Laboratory of Protein Design and Immunoengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland., Inel D; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., van Dalen FJ; Department of Medical Biosciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Institute for Chemical Immunology, Nijmegen, The Netherlands., Viertl D; Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and Molecular Imaging and of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; In Vivo Imaging Facility, Department of Research and Training, University of Lausanne (UNIL), Lausanne, Switzerland., Lau K; Protein Production and Structure Core Facility, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland., Pojer F; Protein Production and Structure Core Facility, School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland., Schottelius M; Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and Molecular Imaging and of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.; AGORA Pôle de Recherche sur le Cancer, Lausanne, Switzerland., Zoete V; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Verdoes M; Department of Medical Biosciences, Radboud University Medical Center, Nijmegen, The Netherlands.; Institute for Chemical Immunology, Nijmegen, The Netherlands., Arber C; Ludwig Institute for Cancer Research, Lausanne Branch, Lausanne, Switzerland.; Department of Oncology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Correia BE; Laboratory of Protein Design and Immunoengineering, School of Engineering, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. bruno.correia@epfl.ch., Oricchio E; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland. elisa.oricchio@epfl.ch.; Swiss Cancer Center Leman (SCCL), Lausanne, Switzerland. elisa.oricchio@epfl.ch.
Publikováno v:
Nature chemical biology [Nat Chem Biol] 2024 Sep; Vol. 20 (9), pp. 1188-1198. Date of Electronic Publication: 2024 May 29.
Autor:
Vanhove C; Department of Electronics and Information Systems, Faculty of Engineering and Architecture, Campus UZ Gent, Institute Biomedical Engineering and Technology (IBiTech), Corneel Heymanslaan 10, 9000, Ghent, Belgium. Christian.Vanhove@UGent.be., Koole M; Nuclear Medicine and Molecular Imaging, KU Leuven, Louvain, Belgium., Fragoso Costa P; Department of Nuclear Medicine, University Hospital Essen, West German Cancer Center (WTZ), University of Duisburg-Essen, Essen, Germany., Schottelius M; Unit of Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Mannheim J; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard-Karls University Tübingen, Tübingen, Germany., Kuntner C; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Warnock G; University of Zurich, Zurich, Switzerland.; PMOD Technologies LLC, Fällanden, Switzerland., McDougald W; BHF-University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.; Siemens, Molecular Imaging, Hoffman Estates,, IL, USA., Tavares A; BHF-University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.; Edinburgh Imaging, University of Edinburgh, Edinburgh, UK., Bernsen M; AMIE Core Facility, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Aug 29. Date of Electronic Publication: 2024 Aug 29.
Autor:
Martin S; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Wendlinger L; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Zitti B; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Hicham M; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; Department of Pathology and Immunology, University of Geneva, Geneva, Switzerland., Postupalenko V; Debiopharm Research & Manufacturing SA, Campus 'après-demain', Rue du Levant 146, Martigny, 1920, Switzerland., Marx L; Debiopharm Research & Manufacturing SA, Campus 'après-demain', Rue du Levant 146, Martigny, 1920, Switzerland., Giordano-Attianese G; Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, 1066, Switzerland.; Department of Oncology, University Hospital of Lausanne, Lausanne, 1011, Switzerland., Cribioli E; Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, 1066, Switzerland.; Department of Oncology, University Hospital of Lausanne, Lausanne, 1011, Switzerland., Irving M; Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, 1066, Switzerland.; Department of Oncology, University Hospital of Lausanne, Lausanne, 1011, Switzerland., Litvinenko A; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Faizova R; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Viertl D; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Schottelius M; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine, Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, 1011, Switzerland. margret.schottelius@chuv.ch.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland. margret.schottelius@chuv.ch.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland. margret.schottelius@chuv.ch.
Publikováno v:
EJNMMI research [EJNMMI Res] 2024 Aug 28; Vol. 14 (1), pp. 77. Date of Electronic Publication: 2024 Aug 28.
Autor:
Buckle T; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands., Rietbergen DDD; Interventional Molecular Imaging Laboratory, Leiden University Medical Center, Leiden, The Netherlands.; Section Nuclear Medicine, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., de Wit-van der Veen L; Department of Nuclear Medicine, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Schottelius M; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), University of Lausanne, Rue du Bugnon 25A, Agora, Lausanne, CH-1011, Switzerland. margret.schottelius@chuv.ch.; Agora, pôle de recherche sur le cancer, Lausanne, Switzerland. margret.schottelius@chuv.ch.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Aug; Vol. 51 (10), pp. 3040-3054. Date of Electronic Publication: 2024 Jun 20.
Autor:
Vanhove C; Department of Electronics and Information Systems, Faculty of Engineering and Architecture, Campus UZ Gent, Institute Biomedical Engineering and Technology (IBiTech), Corneel Heymanslaan 10, 9000, Ghent, Belgium. Christian.Vanhove@UGent.be., Koole M; Nuclear Medicine and Molecular Imaging, KU Leuven, Louvain, Belgium., Fragoso Costa P; Department of Nuclear Medicine, University Hospital Essen, West German Cancer Center (WTZ), University of Duisburg-Essen, Essen, Germany., Schottelius M; Unit of Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland., Mannheim J; Department of Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, Eberhard-Karls University Tübingen, Tübingen, Germany., Kuntner C; Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria., Warnock G; University of Zurich, Zurich, Switzerland.; PMOD Technologies LLC, Fällanden, Switzerland., McDougald W; BHF-University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.; Siemens, Molecular Imaging, Hoffman Estates,, IL, USA., Tavares A; BHF-University Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, UK.; Edinburgh Imaging, University of Edinburgh, Edinburgh, UK., Bernsen M; AMIE Core Facility, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul 15. Date of Electronic Publication: 2024 Jul 15.
Autor:
Martin S; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Rue du Bugnon 25A, Agora, Lausanne, CH-1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Wendlinger L; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Rue du Bugnon 25A, Agora, Lausanne, CH-1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Litvinenko A; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Rue du Bugnon 25A, Agora, Lausanne, CH-1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Faizova R; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Rue du Bugnon 25A, Agora, Lausanne, CH-1011, Switzerland.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland., Schottelius M; Translational Radiopharmaceutical Sciences, Department of Nuclear Medicine and Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Rue du Bugnon 25A, Agora, Lausanne, CH-1011, Switzerland. margret.schottelius@chuv.ch.; AGORA, Pôle de recherche sur le cancer, Lausanne, 1011, Switzerland. margret.schottelius@chuv.ch.; SCCL Swiss Cancer Center Leman, Lausanne, 1011, Switzerland. margret.schottelius@chuv.ch.
Publikováno v:
EJNMMI radiopharmacy and chemistry [EJNMMI Radiopharm Chem] 2024 Mar 21; Vol. 9 (1), pp. 23. Date of Electronic Publication: 2024 Mar 21.
Autor:
Enke JS; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Reitsam NG; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Grosser B; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Kircher M; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Dierks A; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Bundschuh RA; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.; Bavarian Center for Cancer Research (BKFZ), Erlangen, Germany., Wienand G; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany., Uhrmacher L; Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany; and., Trepel M; Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany; and., Schottelius M; Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and Oncology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland., Lapa C; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany; constantin.lapa@uk-augsburg.de.; Bavarian Center for Cancer Research (BKFZ), Erlangen, Germany., Pfob CH; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Jan 02; Vol. 65 (1), pp. 163-164. Date of Electronic Publication: 2024 Jan 02.
Autor:
Postupalenko V; Institute of Life Technologies, HES-SO Valais-Wallis Rue de l'Industrie 23 CH-1950 Sion Switzerland origene.nyanguile@hevs.ch., Marx L; Debiopharm Research & Manufacturing SA Campus 'après-demain', Rue du Levant 146 1920 Martigny Switzerland., Pantin M; Debiopharm Research & Manufacturing SA Campus 'après-demain', Rue du Levant 146 1920 Martigny Switzerland., Viertl D; Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and of Oncology, CHUV/UNIL 1011 Lausanne Switzerland.; In Vivo Imaging Facility, Department of Research and Training, University of Lausanne CH-1011 Lausanne., Gsponer N; Institute of Life Technologies, HES-SO Valais-Wallis Rue de l'Industrie 23 CH-1950 Sion Switzerland origene.nyanguile@hevs.ch., Giudice G; Institute of Life Technologies, HES-SO Valais-Wallis Rue de l'Industrie 23 CH-1950 Sion Switzerland origene.nyanguile@hevs.ch., Gasilova N; EPFL Valais Wallis, MSEAP, ISIC-GE-VS rue de l'Industrie 17 1951 Sion Switzerland., Schottelius M; Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and of Oncology, CHUV/UNIL 1011 Lausanne Switzerland.; Agora, pôle de recherche sur le cancer 1011 Lausanne Switzerland., Lévy F; Debiopharm International SA Forum 'après-demain', Chemin Messidor 5-7, Case postale 5911 1002 Lausanne Switzerland., Garrouste P; Debiopharm Research & Manufacturing SA Campus 'après-demain', Rue du Levant 146 1920 Martigny Switzerland., Segura JM; Institute of Life Technologies, HES-SO Valais-Wallis Rue de l'Industrie 23 CH-1950 Sion Switzerland origene.nyanguile@hevs.ch., Nyanguile O; Institute of Life Technologies, HES-SO Valais-Wallis Rue de l'Industrie 23 CH-1950 Sion Switzerland origene.nyanguile@hevs.ch.
Publikováno v:
Chemical science [Chem Sci] 2023 Dec 14; Vol. 15 (4), pp. 1324-1337. Date of Electronic Publication: 2023 Dec 14 (Print Publication: 2024).
Autor:
Wang H; Department of Nuclear Medicine, West China Hospital, Sichuan University, Guo Xue Xiang 37, Chengdu, 610040, Sichuan, China. wanghui_5349@outlook.com.; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany. wanghui_5349@outlook.com., Remke M; Institute of Pathology, School of Medicine, Technical University Munich, Munich, Germany., Horn T; Department of Urology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany., Schwamborn K; Institute of Pathology, School of Medicine, Technical University Munich, Munich, Germany., Chen Y; Departments of Mathematics and Life Sciences, Technical University Munich, Munich, Germany., Steiger K; Institute of Pathology, School of Medicine, Technical University Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Weichert W; Institute of Pathology, School of Medicine, Technical University Munich, Munich, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany., Wester HJ; Pharmaceutical Radiochemistry, Technical University Munich, Munich, Germany., Schottelius M; Translational Radiopharmaceutical Sciences, Departments of Nuclear Medicine and of Oncology, Centre Hospitalier Universitaire Vaudois, University of Lausanne, Lausanne, Switzerland.; Agora, Pole de Recherche Sur Le Cancer, Lausanne, Switzerland., Weber WA; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany., Eiber M; Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University Munich, Ismaninger Str. 22, 81675, Munich, Germany. matthias.eiber@tum.de.
Publikováno v:
EJNMMI research [EJNMMI Res] 2023 Nov 16; Vol. 13 (1), pp. 99. Date of Electronic Publication: 2023 Nov 16.